Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA decision on BPA due by Nov. 30

This article was originally published in The Tan Sheet

Executive Summary

Following internal and external scientific reviews of the potential risks of low-dose exposure to bisphenol A, the agency will decide how to proceed by Nov. 30, according to acting Chief Scientist Jesse Goodman. Should FDA determine the chemical does not meet the standard of reasonable certainty of no harm, it "would announce its intent to initiate formal rulemaking to repeal or restrict some or all uses of BPA in food contact substances," Goodman said at the FDA Science Board meeting Aug. 17. Likewise, if BPA is found to meet the standard, FDA would release the review assessment, explain the results and provide advice for consumers, he added. Commissioner Margaret Hamburg told lawmakers in June of FDA's intent to reassess whether BPA is safe in food and beverage containers; the food safety bill passed by the House, H.R. 2749, would require FDA to advise Congress of its conclusion on BPA by the end of 2009 (1"The Tan Sheet" June 22, 2009)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103250

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel